BACE1 and Alzheimer disease: Consequently, we indicated that berberine could act as a high-affinity BACE1 inhibitor and prevented Aβ1-42 aggregation to delay the pathological process of AD, which further demonstrated that berberine tended to be beneficial for the patients with AD.